MPO and infarction: The pro-inflammatory activation [evidenced by TNF-α, IL-1β, myeloperoxidase (MPO) activity, and oxidative DNA damage] was reduced and a satisfactory cardiac function was maintained 4 weeks post-infarction with, among others, improved left ventricular ejection fraction, diastolic volume and contractility compared to non-CH4-treated animals.